Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients

BACKGROUND: The current standard treatment for neovascular age-related macular degeneration (nAMD) involves intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) agents. The aim of the present study was to compare the effectiveness and safety of two anti-VEGF drugs: broluciz...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Sanjay Kumar, Kumar, Pradeep, Khullar, Srishti, Joshi, Amrita, Sati, Alok, Kumar, Sonali Vinay, Unni, Deepesh, Kumar, Atul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331073/
https://www.ncbi.nlm.nih.gov/pubmed/35902887
http://dx.doi.org/10.1186/s40942-022-00401-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331073/
https://www.ncbi.nlm.nih.gov/pubmed/35902887
http://dx.doi.org/10.1186/s40942-022-00401-4

Ejemplares similares